Granules India is currently trading at Rs. 143.00, up by 3.05 points or 2.18 % from its previous closing of Rs. 139.95 on the BSE.
The scrip opened at Rs. 140.40 and has touched a high and low of Rs. 144.75 and Rs. 138.80 respectively. So far 146604 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 157.00 on 18-May-2017 and a 52 week low of Rs. 91.45 on 09-Nov-2016.
Last one week high and low of the scrip stood at Rs. 144.75 and Rs. 131.50 respectively. The current market cap of the company is Rs. 3292.47 crore.
The promoters holding in the company stood at 53.45%, while Institutions and Non-Institutions held 11.54% and 35.01% respectively.
Granules India has received an approval to increase the present limit of FII / FPIs shareholding in the company to 49% of the total paid-up equity share capital of the company. The board of directors at their meeting held on July 5, 2017, has approved for the same.
Granules India, the Hyderabad-head quartered company, manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates and finished dosages. It intends to increase its global presence with a firm base and operations in the US.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1786.05 |
Dr. Reddys Lab | 1354.20 |
Cipla | 1470.05 |
Lupin | 2190.50 |
Zydus Lifesciences | 1004.05 |
View more.. |